Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files to Sell Another $1.04 Million in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$52.1
Mkt Cap
$1.516B
52W Low
$11.402
52W High
$72.36
52W Position info
357% above low
Off High info
28% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

Officer Dennis Mulroy has filed a Form 144 to sell an additional $1.04 million in company stock, continuing a recent trend of significant insider selling.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files Intent to Sell

    Officer Dennis Mulroy has filed a Form 144 to sell 20,000 shares of common stock, valued at approximately $1,046,560.00.

  • Continuation of Selling Pattern

    This filing marks a continuation of a recent trend, with Mulroy having sold 222,900 shares totaling over $12.1 million in gross proceeds over the past three months.

  • Acquisition via Option Exercise

    The shares intended for sale were acquired through a stock option exercise on the same day as the proposed sale.

  • Contrasts Share Repurchase Program

    This ongoing insider selling occurs while the company recently announced a $100 million share repurchase program.


Analysis · ANAB · Life Sciences

Officer Dennis Mulroy continues a pattern of significant stock sales, filing intent to sell an additional $1.04 million worth of shares. This ongoing disposition, following multiple similar filings in recent days, indicates a sustained reduction in his holdings. This activity contrasts with the company's recently announced $100 million share repurchase program.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $52.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $50.26 info
Change: -$0.590 (-1%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:23 PM EDT
Filing Type: 10-KT
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Jun 29, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.97
Real-time Price: $50.26 info
Change: -$15.71 (-24%) info
Market Cap: $1.503B info